Palvella Therapeutics, Inc

Zynerba Pharmaceuticals, Inc. is an orphan-focused, neuropsychiatric biopharmaceutical company based in Devon, PA. They are dedicated to developing innovative transdermal cannabinoid treatments for patients with rare neurological diseases, with a particular focus on improving the lives of those battling certain rare conditions. Recently acquired by Harmony Biosciences, Zynerba Pharmaceuticals is at the forefront of pioneering cannabinoid therapies for neuropsychiatric conditions. Their ongoing RECONNECT clinical trial is open for recruitment, offering patients, families, and healthcare providers an opportunity to learn more about Fragile X syndrome and access potential treatments. With a mission to advance science and improve connections, Zynerba Pharmaceuticals is committed to addressing unmet medical needs in the field of rare disorders.Generated from the website

CSL Behring, located in King of Prussia, PA, is a leading biotechnology company that specializes in the development and production of plasma-derived and recombinant therapies for rare and serious diseases. With a focus on patient support and public health, CSL Behring offers a wide range of treatments for conditions such as immunodeficiency, autoimmune diseases, hereditary bleeding disorders, and iron deficiency. As part of their commitment to innovation and sustainability, CSL Behring also invests in research and development, with expertise in plasma protein technology, recombinant technology, cell and gene therapy, and vaccines. They strive to provide a positive working environment and support diversity, equity, and inclusion in their workforce. Through their dedication to improving patient outcomes and their contributions to the community, CSL Behring continues to be a leader in the biotech industry.Generated from the website

From the website:Find directions and information about Main Line Health's corporate office locations in Berwyn, Newtown Square and Radnor, Pennsylvania.